Keyphrases
Phosphoprotein
93%
Dopamine
93%
Prostate Cancer
93%
Coronary Artery Disease
89%
Hemangioblast
70%
Overexpression
65%
Neoepitope
62%
Poor Outcome
58%
SNP
54%
RNA Sequencing (RNA-seq)
52%
Metastasis
52%
Predictive Biomarker
52%
Neoantigen
50%
Tumor Cell Proliferation
46%
Epidermal Growth Factor Receptor
46%
ErbB3
46%
Lung Adenocarcinoma
46%
Molecular Targeted Therapy
46%
Small Cell Lung Cancer
46%
Cyclic Adenosine Monophosphate (cAMP)
46%
Neuroendocrine Tumor Cells
46%
AGGF1
46%
Achaete-scute Homolog 1
46%
Rs17465637
46%
MIA3
46%
Ischemic Stroke
46%
Endothelial Barrier
46%
Mouse Limb
46%
Signal Transducer and Activator of Transcription 3
46%
RNA-seq Data
46%
Meta-analysis
46%
RNA Splicing Factors
46%
Transcriptome Analysis
46%
ROBO1
46%
Vascular Development
46%
Cancer Subtypes
46%
Regulatory Axis
46%
19p13.2
46%
Single nucleotide Polymorphism
46%
Vascular Permeability
46%
Cancer Transcriptome
46%
BRG1
46%
Angiogenic Factors
46%
Limb Ischemia
46%
Myelopoiesis
46%
Aggressive Tumor
46%
Exitron
46%
Via Resistance
46%
Cancer Growth
46%
DOCK1
46%
Biochemistry, Genetics and Molecular Biology
Zebra Fish
100%
Phosphoprotein
93%
Cyclic Adenosine Monophosphate
93%
Angiogenesis
67%
Allele
65%
Mouse
64%
Hemangioblast
62%
Genetics
60%
Single Nucleotide Polymorphism
56%
Genome Wide Association Study
52%
Tumor Progression
51%
Indel
46%
Gene Expression Profiling
46%
Myelopoiesis
46%
RNA Splicing
46%
Hematopoiesis
46%
Vascularization
46%
RNA Sequencing
46%
Promoter Region
46%
Atrial Fibrillation
46%
Gene Interaction
46%
Blood Vessel Permeability
46%
ERBB3
46%
Cell Proliferation
46%
Splicing Factor
46%
RNA Sequence
46%
Gene Expression
46%
EC50
46%
High Risk Population
46%
STAT3
46%
Single-Nucleotide Polymorphism
46%
Epidermal Growth Factor Receptor
46%
Vascular Endothelial Growth Factor
46%
Guanosine Triphosphate
46%
Somatic Mutation
46%
Exon
46%
Catenin
46%
Major Histocompatibility Complex
46%
Transcriptome
46%
Proteome
46%
Intron
46%
Myeloid
46%
SMARCA4
31%
Cancer Cell
26%
Blood Flow
23%
Genotyping
18%
Isoform
17%
Receptor Tyrosine Kinase Inhibitors
17%
Erythropoiesis
15%
Protein Kinase B
15%